Zevra Therapeutics (ZVRA) Stock Chart & Stock Price History → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free ZVRA Stock Alerts $4.73 -0.03 (-0.63%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Zevra Therapeutics Stock Price Performance5 Day Performance-1.46%1 Month Performance+4.65%3 Month Performance-31.05%6 Month Performance+8.99%Year-To-Date Performance-27.79%1 Year Performance-12.41% Receive ZVRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs ZVRA Stock Chart for Sunday, May, 19, 2024 ZVRA Chart by TradingView Zevra Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$4.76$4.73-0.63%$4.84$4.67142,373 shs$197.95 million05/16/2024$4.82$4.76-1.24%$4.90$4.75175,602 shs$199.22 million05/15/2024$4.80$4.82+0.42%$4.97$4.81157,625 shs$201.72 million05/14/2024$4.89$4.80-1.84%$5.00$4.76191,944 shs$200.88 million05/13/2024$4.82$4.89+1.45%$5.05$4.75355,318 shs$204.65 million05/10/2024$5.03$4.82-4.17%$5.05$4.77250,744 shs$209.33 million Get the Latest News and Ratings for ZVRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$5.16$5.03-2.52%$5.26$5.03190,164 shs$218.45 million05/08/2024$5.18$5.16-0.29%$5.24$4.80229,449 shs$224.10 million05/07/2024$5.16$5.18+0.39%$5.30$5.11305,903 shs$224.75 million05/06/2024$4.81$5.16+7.17%$5.18$4.87309,792 shs$223.86 million05/03/2024$4.75$4.81+1.26%$4.96$4.79169,537 shs$208.90 million05/02/2024$4.60$4.75+3.26%$4.78$4.61125,611 shs$206.29 million05/01/2024$4.58$4.60+0.44%$4.77$4.58174,402 shs$199.76 million04/30/2024$4.55$4.58+0.66%$4.63$4.50116,742 shs$198.91 million04/29/2024$4.52$4.55+0.66%$4.64$4.52106,915 shs$197.61 million04/26/2024$4.52$4.52$4.60$4.48157,431 shs$196.30 million04/25/2024$4.56$4.52-0.88%$4.56$4.48127,280 shs$196.30 million04/24/2024$4.58$4.56-0.44%$4.60$4.49158,593 shs$198.04 million04/23/2024$4.57$4.58+0.22%$4.68$4.54136,170 shs$198.91 million04/22/2024$4.52$4.57+1.11%$4.63$4.46108,434 shs$198.46 million04/19/2024$4.50$4.52+0.44%$4.63$4.39363,829 shs$196.30 million04/18/2024$4.64$4.50-3.02%$4.65$4.46261,825 shs$195.44 million04/17/2024$4.77$4.64-2.73%$4.81$4.64211,292 shs$201.50 million04/16/2024$4.79$4.77-0.31%$4.89$4.69191,409 shs$207.16 million04/15/2024$4.80$4.79-0.31%$4.93$4.75244,546 shs$207.81 million04/12/2024$4.94$4.80-2.83%$5.00$4.73211,066 shs$208.46 million04/11/2024$4.92$4.94+0.41%$4.96$4.78155,180 shs$214.54 million04/10/2024$4.73$4.92+4.02%$5.07$4.67349,754 shs$213.68 million04/09/2024$4.94$4.73-4.25%$4.95$4.68215,218 shs$205.42 million04/08/2024$4.82$4.94+2.49%$5.01$4.80183,361 shs$214.54 million04/05/2024$4.91$4.82-1.83%$4.98$4.80192,240 shs$209.33 million04/04/2024$5.03$4.91-2.39%$5.14$4.85263,380 shs$177.84 million04/03/2024$5.12$5.03-1.66%$5.17$4.98531,170 shs$182.18 million04/02/2024$5.16$5.12-0.87%$5.34$5.11234,751 shs$185.27 million04/01/2024$5.80$5.16-11.03%$5.49$5.02600,885 shs$186.90 million03/29/2024$5.80$5.80$6.35$5.74327,658 shs$210.08 million03/28/2024$5.94$5.80-2.36%$6.35$5.74316,996 shs$210.08 million03/27/2024$5.72$5.94+3.85%$5.97$5.74252,028 shs$215.15 million03/26/2024$5.64$5.72+1.42%$5.84$5.62188,092 shs$207.18 million03/25/2024$5.76$5.64-2.08%$5.87$5.59226,474 shs$204.28 millionHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs03/22/2024$5.84$5.76-1.37%$5.99$5.75224,975 shs$208.63 million03/21/2024$6.04$5.84-3.31%$6.11$5.83224,420 shs$211.53 million03/20/2024$5.95$6.04+1.51%$6.10$5.83155,487 shs$218.77 million03/19/2024$5.96$5.95-0.17%$6.02$5.87161,236 shs$215.51 million03/18/2024$6.00$5.96-0.67%$6.06$5.87213,005 shs$215.87 million03/15/2024$6.15$6.00-2.44%$6.35$5.99595,080 shs$217.32 million03/14/2024$6.28$6.15-2.07%$6.24$6.10201,439 shs$222.74 million03/13/2024$6.24$6.28+0.64%$6.41$6.18197,493 shs$227.45 million03/12/2024$6.13$6.24+1.79%$6.48$6.21213,210 shs$226.01 million03/11/2024$6.10$6.13+0.49%$6.18$5.95232,293 shs$222.03 million03/08/2024$6.31$6.10-3.33%$6.40$6.10127,456 shs$220.94 million03/07/2024$6.25$6.31+0.96%$6.43$6.26205,405 shs$228.55 million03/06/2024$5.91$6.25+5.75%$6.39$5.93261,211 shs$226.38 million03/05/2024$6.22$5.91-4.98%$6.33$5.77384,644 shs$214.06 million03/04/2024$7.08$6.22-12.15%$6.68$6.07796,300 shs$225.28 million03/01/2024$6.74$7.08+5.04%$7.10$6.71181,544 shs$256.44 million02/29/2024$6.86$6.74-1.75%$6.95$6.66189,055 shs$244.12 million02/28/2024$6.95$6.86-1.29%$7.04$6.78171,732 shs$248.47 million02/27/2024$6.87$6.95+1.16%$7.07$6.76191,955 shs$251.73 million02/26/2024$6.63$6.87+3.62%$6.97$6.59211,691 shs$248.83 million02/23/2024$6.80$6.63-2.50%$6.88$6.60173,691 shs$240.14 million02/22/2024$6.78$6.80+0.29%$7.07$6.74178,395 shs$246.30 million02/21/2024$6.89$6.78-1.60%$7.03$6.62219,143 shs$245.57 million02/20/2024$6.86$6.89+0.44%$7.28$6.80288,888 shs$249.56 million02/19/2024$6.86$6.86$7.10$6.56492,100 shs$248.47 million Related Companies: Trevi Therapeutics Stock Price Chart Incannex Healthcare Stock Price Chart Atossa Therapeutics Stock Price Chart Conduit Pharmaceuticals Stock Price Chart Inventiva Stock Price Chart Organigram Stock Price Chart Acrivon Therapeutics Stock Price Chart Werewolf Therapeutics Stock Price Chart Telomir Pharmaceuticals Stock Price Chart Veru Stock Price Chart Receive ZVRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ZVRA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaUrgent Nvidia WarningAltimetryThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zevra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.